Five things for pharma marketers to know: Wednesday, November 9, 2016

1. In a shocking upset, Donald Trump won the presidential election, bringing in 279 electoral votes compared to Hillary Clinton's 218. Trump, the Republican candidate, has broken with Republican tradition to voice support to allow Medicare to negotiate drug prices, a position that has been a common refrain in Democratic circles. He also supports importing drugs from other countries and price transparency for the healthcare system. Yet when it comes to the Affordable Care Act, he toes the party line and has promised to repeal and replace the legislation. (Stat)

2. Drugmakers are already benefitting from Trump's win, with futures on pharmaceutical companies like Endo, Mylan, and Perrigo increasing sharply. (WSJ)

3. A California ballot measure that would allow state health programs to pay the same prices as the Department of Veterans Affairs for drugs is likely headed for defeat. Drugmakers spent more than $100 million fighting the measure. (Reuters)

4. Voters in California, Massachusetts, and Nevada won the fight for recreational marijuana use, while Arkansas, Florida, and North Dakota voted in support of medical marijuana legalization. (The Guardian)   

5. CVS Health told investors it may lose 40 million prescriptions in 2017 due to supply-chain deals signed by Walgreens Boots Alliance that exclude access to CVS stores. (Dow Jones)